Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of esophageal cancer in at-risk patients.
Proteomics locks in US patent for throat cancer test
Published 4 hours ago
Source: smh.com.au
Categories
Business / Companies
Related Articles from smh.com.au
2 minutes ago
Accused CBD stabber gets bail, but won't be released
4 minutes ago
NSW Premier signals sweeping changes to state’s gun laws
6 minutes ago
Bondi Beach tragedy puts spotlight on gun ownership
6 minutes ago
Grieving loved ones lay flowers at Bondi Pavilion
7 minutes ago
Families allowed inside Bondi Beach crime scene
12 minutes ago